Epitalon — Apex Research Reference

01 / IDENTITY

Compound Profile

4

AMINO ACIDS

~0.39

kDa MW

SC/IV

ROUTE

50mg

VIAL SIZE

SEQUENCE

Ala-Glu-Asp-Gly (AEDG)

CLASSIFICATION

Synthetic tetrapeptide analog of epithalamin — the bioregulator peptide naturally secreted by the pineal gland. Epitalon is the synthetic, more stable version of the natural pineal extract.

PRIMARY MECHANISM

Activates telomerase (hTERT) → elongates/maintains telomeres. Regulates pineal melatonin production → circadian rhythm normalization. Activates PCNA (proliferating cell nuclear antigen) → DNA repair. Antioxidant upregulation via Nrf2 pathway.

DEVELOPER

Prof. Vladimir Khavinson, St. Petersburg Institute of Bioregulation and Gerontology, Russia. Developed 1980s–1990s from research on hypothalamic/pineal bioregulators and aging.

WHY UNIQUE

Epitalon is one of the very few compounds with published human data showing actual telomere lengthening. Most "telomere" supplements have no such evidence. Khavinson's group published longitudinal data from elderly patients over 12+ years.

ORAL BIOAVAILABILITY

Surprisingly good for a peptide — some studies suggest sublingual/oral absorption. However, SC injection provides the most reliable bioavailability for clinical endpoints.

02 / RESEARCH HISTORY

Development Timeline

1970s–1980s

Vladimir Khavinson at the St. Petersburg Institute begins research on pineal gland extracts and their relationship to aging. Epithalalin — the crude pineal extract — shows anti-aging effects in animal models: extended lifespan, reduced cancer incidence, normalized hormone rhythms.

1989

Khavinson synthesizes Epitalon (AEDG tetrapeptide) — the active component of epithalamin. Simpler to manufacture, more stable, fully synthetic. Animal studies confirm longevity-extending effects: mice treated with Epitalon show 25–30% lifespan extension vs. controls in some studies.

2003

Landmark publication: Khavinson et al. demonstrate Epitalon activates telomerase in human fetal fibroblasts and somatic cells — the first peptide shown to directly elongate telomeres in human cells. Published in Bulletin of Experimental Biology and Medicine and later confirmed in multiple follow-up studies.

2006–2012

Long-term human cohort data published: elderly patients (65–80 years) treated with Epitalon over 12 years show reduced mortality rates, improved sleep and circadian rhythms, better melatonin regulation, reduced cancer incidence, and measurable telomere preservation vs. untreated age-matched controls.

2014–2024

Mechanism elucidated in detail — Epitalon activates hTERT gene expression, upregulates Nrf2 antioxidant response, normalizes cortisol/melatonin rhythms, and reduces DNA damage markers. Western research community adopts Epitalon as longevity protocol component. Widely available as research compound.

      Key Data Point: In a 12-year follow-up study of elderly patients, Epitalon treatment was associated with 28% lower mortality vs. control group. Mean telomere length was preserved in the treatment group while controls showed progressive shortening. This remains some of the strongest long-term human data for any longevity peptide.
    

03 / BENEFITS

Primary Effects

01

Telomere Lengthening & Telomerase Activation

The defining mechanism: Epitalon activates hTERT (human telomerase reverse transcriptase) gene expression. Telomeres are the protective caps on chromosomes — they shorten with each cell division (the "biological clock"). Telomerase rebuilds them. Epitalon is one of the few compounds with published evidence of actual telomere lengthening in human cells.

02

Circadian Rhythm & Melatonin Regulation

As a pineal peptide, Epitalon normalizes melatonin secretion — particularly the age-related decline in nocturnal melatonin production. Restores more youthful cortisol/melatonin patterns. Clinically: improved sleep quality, faster sleep onset, reduced waking, normalized circadian gene expression (BMAL1, PER2, CLOCK).

03

Cancer Prevention & DNA Integrity

Multiple mechanisms converge on cancer prevention: telomere maintenance prevents chromosomal instability, DNA repair upregulation reduces mutation accumulation, antioxidant activation reduces oxidative DNA damage. Long-term cohort studies show reduced cancer incidence in Epitalon-treated elderly patients.

04

Antioxidant Upregulation (Nrf2)

Epitalon activates the Nrf2/ARE pathway — the master antioxidant transcription factor that upregulates SOD, catalase, glutathione peroxidase, and other endogenous antioxidant enzymes. Reduces oxidative stress markers (8-OH-dG, MDA) and protects mitochondria from ROS damage.

05

Retinal & Visual Function Preservation

Unique among longevity peptides: Epitalon has documented benefit for age-related retinal degeneration. Russian trials showed improved retinal sensitivity and visual acuity in elderly patients with degenerative eye disease. Mechanism: cytoprotection of photoreceptors and RPE cells via antioxidant and anti-inflammatory pathways.

06

Neurological & Cognitive Support

Pineal-hypothalamic axis regulation affects the entire neuroendocrine system. Epitalon treatment normalizes GH/IGF-1 axis, cortisol rhythms, and neurotransmitter balance. Reported effects: improved memory, reduced age-associated cognitive decline, better stress resilience. Neuroprotective against oxidative stress in CNS.

04 / RECONSTITUTION

Preparation Protocol

// 50MG VIAL — STANDARD RECONSTITUTION

50,000 mcg ÷ 300 units BAC water = 166.6 mcg per unit

Add 3.0 mL (300 units) bacteriostatic water to 50mg lyophilized vial.

TARGET DOSE	UNITS TO DRAW	VOLUME	NOTE
LOW5 mg5,000 mcg	30 units	0.30 mL	Maintenance / shorter cycle
STANDARD10 mg10,000 mcg	60 units	0.60 mL	Most common protocol dose
HIGH20 mg20,000 mcg	120 units	1.20 mL	Accelerated cycle; intensive protocol

Vial yield: 50mg vial at 10mg/day = 5 doses (one standard 5-day cycle). At 5mg/day = 10 doses. The 50mg vial is designed for a complete short-cycle protocol.

Storage: Lyophilized — refrigerate (2–8°C), protect from light. Reconstituted: refrigerate, stable for 30 days. Epitalon is a small, stable tetrapeptide — one of the more stable peptides once reconstituted.

05 / DOSING PROTOCOL

Administration Guide

PROTOCOL	DOSE	SCHEDULE	DURATION	CONTEXT
SHORT PULSE	5–10 mg SC	Daily × 10 days	10 days on / 3–6 months off	Classic Khavinson protocol — most studied
EXTENDED	5 mg SC	Daily × 20 days	20 days on / 4–6 months off	More sustained telomere effect
QUARTERLY	10 mg SC	Daily × 10 days	Every 3–4 months	Ongoing longevity maintenance protocol
ANNUAL	10–20 mg SC	Daily × 10 days	Once annually	Minimum longevity protocol; budget-conscious

Pulsed Protocol Rationale: Epitalon works through gene expression changes (hTERT upregulation, Nrf2 activation) that persist well beyond the dosing period. Unlike daily-maintenance peptides, Epitalon produces lasting epigenetic changes — pulsed protocols are both more practical and clinically consistent with Khavinson's original research design.

06 / TIMING

Administration Timing

PREFERRED WINDOW

Evening, 30–60 minutes before sleep. Rationale: aligns with pineal gland activity (melatonin synthesis occurs nocturnally), supports circadian normalization effects, and may enhance sleep quality as a direct benefit.

FOOD STATE

Fasted preferred — some data suggests Epitalon absorption is better without food competing in the GI system. SC injection bypasses this concern; timing relative to food is less critical than for oral compounds.

STACKING

Epitalon + NAD+ = comprehensive anti-aging stack (telomere + sirtuin + DNA repair). Add GHK-Cu for tissue remodeling layer. FOX04-DRI (senolytic) timed separately — clear senolytics first, then Epitalon for telomere maintenance.

CYCLE FREQUENCY

Most evidence supports quarterly pulsing (4 courses/year). Some longevity practitioners use 2 courses/year. Annual is the minimum to maintain biological age benefits based on cohort data.

07 / BIOMARKERS

Monitoring Panel

// TELOMERE & BIOLOGICAL AGE

MARKER	TEST	CLINICAL RANGE	OPTIMAL / TARGET
Telomere Length (LTL)Leukocyte Telomere Length	Life Length, Repeat Diagnostics, or SpectraCell	CLINAge-normalized (decreases ~50 bp/year)	OPT75th+ percentile for age; stable or increasing on treatment
Epigenetic AgeDNA Methylation Clock	TruAge, myDNAge, Horvath Clock	CLIN≈ Chronological age ± 5 years	OPT>5 years younger than chronological; improving over cycles
GrimAge ScoreMortality Predictor Clock	TruAge or Elysium Index	CLIN≈ Chronological age	OPTSignificantly younger; improving annually

// HORMONAL & CIRCADIAN MARKERS

MARKER	TEST	CLINICAL RANGE	OPTIMAL
Melatonin (nocturnal)Urinary 6-sulfatoxymelatonin or AM serum	24h urine or LabCorp serum	CLINHighly variable; peaks 2–4 AM	OPTNormal nocturnal peak restored; improved sleep architecture
AM CortisolDiurnal Cortisol Rhythm	8 AM serum draw	CLIN6–23 mcg/dL (AM peak)	OPTNormal AM peak (10–20 mcg/dL) with evening trough <3 mcg/dL
IGF-1Growth Hormone Axis	AM fasting serum	CLINAge-dependent normal range	OPTUpper-normal for age (Epitalon normalizes pineal-GH axis)

// OXIDATIVE STRESS & DNA DAMAGE

MARKER	TEST	CLINICAL RANGE	OPTIMAL
8-OHdG (Oxidative DNA Damage)Urinary 8-hydroxy-2'-deoxyguanosine	Urine collection (lab specialty)	CLIN<15 ng/mg creatinine	OPT<5 ng/mg creatinine (low DNA oxidation)
hs-CRPInflammatory Aging	Standard lab	CLIN<3.0 mg/L	OPT<0.5 mg/L

08 / CYCLE PROTOCOL

Recommended Protocol

10–20

DAYS ACTIVE

Evening

INJECTION TIME

3–4×

PER YEAR

10 mg

STANDARD DOSE

Standard Protocol (Khavinson-derived): 10mg SC nightly for 10 consecutive days. Repeat every 3–4 months. This 4× annual protocol is the most evidence-based approach and aligns with the original Russian clinical trials. One 50mg vial covers two full protocol courses at 10mg/day.

Intensive Anti-Aging: 10mg SC nightly for 20 days, twice yearly (spring + fall). This represents the upper range of standard protocols and provides maximum telomere and epigenetic benefit per year. Particularly recommended for users starting later (50+) or with significant biological age elevation.

Longevity Stack (Annual Protocol):
Q1 (January): FOX04-DRI senolytic (clear aged cells) → Epitalon 10-day course
Q2 (April): NAD+ loading week + Epitalon 10-day course
Q3 (July): GHK-Cu 8-week cycle
Q4 (October): Epitalon 10-day course + NAD+ boost
This quarterly rotation addresses multiple aging hallmarks: senescence, telomere length, NAD+ depletion, and tissue remodeling.

Sleep Protocol Addition: During Epitalon courses, avoid blue light after 9 PM, maintain consistent sleep/wake times, and consider blackout curtains. Epitalon normalizes melatonin secretion — supporting these circadian hygiene practices amplifies the compound's sleep architecture benefits.

Research Compound Notice: Epitalon has been studied in human subjects primarily through Russian research institutions since the 1980s. The published longevity data is compelling but comes primarily from one research group (Khavinson et al.) and has not been fully replicated in large Western RCTs. No FDA approval. No known serious adverse effects reported across decades of use. Telomerase activation carries a theoretical cancer-promotion concern in individuals with pre-existing malignancies — contraindicated in active cancer. For educational and research purposes.